Merck and Pfizer Collaborate with Dako

Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab

28-Sep-2015 - As part of the global strategic alliance between Merck and Pfizer to jointly develop and commercialize avelumab, an investigational immune checkpoint inhibitor, the companies have announced that they have a collaboration agreement in place with Dako, an Agilent Technologies company, for the ...

Pfizer, GSK, and Siemens form R&D Consortium with A*STAR’s Institute of Chemical & Engineering Sciences

New programme aims to help companies increase productivity with technology solutions for pharmaceutical and chemical sectors

21-Jun-2013 - Pfizer Asia Pacific Pte. Ltd, Glaxo Wellcome Manufacturing Pte. Ltd. and Siemens Pte. Ltd, have signed on as founding members of a new A*STAR R&D Consortium Programme - Innovative Processing of Specialties and Pharmaceuticals (iPSP). Launched by A*STAR’s Institute of Chemical and Engineering ...

Urine samples could be used to predict responses to drugs, say researchers

12-Aug-2009 - Researchers may be able to predict how people will respond to particular drugs by analysing their urine samples, suggest scientists behind a new study published in Proceedings of the National Academy of Sciences . Not all drugs are effective in all patients and occasionally, susceptible ...

Chemists synthesize herbal alkaloid

20-Apr-2009 - The club moss Lycopodium serratum is a creeping, flowerless plant used in homeopathic medicine to treat a wide variety of ailments. It contains a potent brew of alkaloids that have attracted considerable scientific and medical interest. However, the plant makes many of these compounds in ...

Accelrys Announces Pfizer Inc. as the First Member of the Enterprise Cheminformatics Consortium

Consortium to Drive the Evolution of Enterprise Cheminformatics Systems Using Open and Flexible Service-Oriented Architecture

05-Feb-2007 - Accelrys, Inc. announced the addition of Pfizer to the Accelrys Enterprise Cheminformatics Consortium. The Consortium will be a collaborative software development project led by Accelrys in partnership with a group of commercial member organizations. Its goal is to prioritize, design, and develop ...

Archemix Announces Collaboration with Pfizer to Discover Aptamer Therapeutics

11-Jan-2007 - Archemix Corp. announced that it has signed an agreement with Pfizer focused on the discovery of first-in-class aptamers for the development and commercialization as therapeutics. As part of the collaboration, Archemix will use its proprietary SELEX technology to discover and generate product ...

Out of REACH

New legislation threatens medicines

21-Nov-2006 - Europe's proposed new chemicals legislation, REACH, could disrupt the supply of important medicines. David Vosvenieks, REACH issue manager at AstraZeneca (AZ), told Chemistry & Industry that two companies supplying intermediates required for two AZ drugs - one of them an anticancer therapy - have ...

Tepnel signs Quality Agreement with Pfizer Ltd for CGMP Services

25-Jul-2006 - Tepnel Life Sciences PLC, a UK-based international Molecular Diagnostics and Research Products & Services group, announced that it's Scottish pharmaceutical services subsidiary, Tepnel Scientific Services Ltd, has entered into a quality agreement with Pfizer. Under the scope of this agreement ...